Rapamycin News and Research

RSS
Rapamycin is a drug used to prevent the rejection of organ and bone marrow transplants by the body. Rapamycin is an antibiotic that blocks a protein involved in cell division and inhibits the growth and function of certain T cells of the immune system involved in the body's rejection of foreign tissues and organs. It is a type of immunosuppressant and a type of serine/threonine kinase inhibitor. Rapamycin is now called sirolimus.
Minimally-invasive deep aging clocks could improve response to COVID-19 vaccine

Minimally-invasive deep aging clocks could improve response to COVID-19 vaccine

Researchers call for trials of rapamycin to treat COVID-19

Researchers call for trials of rapamycin to treat COVID-19

Oncotarget publishes new research on geroscience

Oncotarget publishes new research on geroscience

Gene mutations may explain the poorer outcomes in Hispanic and Latino children with leukemia

Gene mutations may explain the poorer outcomes in Hispanic and Latino children with leukemia

G3BP proteins inhibit metabolic driver that plays a central role in cancers, neurological disorders

G3BP proteins inhibit metabolic driver that plays a central role in cancers, neurological disorders

Anchor proteins inhibit a key metabolic driver that plays critical role in cancer and neuronal diseases

Anchor proteins inhibit a key metabolic driver that plays critical role in cancer and neuronal diseases

New method reveals how pharmaceuticals induce cancer cell death

New method reveals how pharmaceuticals induce cancer cell death

Researchers demonstrate potential preventive treatment for Crohn's disease

Researchers demonstrate potential preventive treatment for Crohn's disease

Study offers new clues to the pathogenesis of glaucoma

Study offers new clues to the pathogenesis of glaucoma

Affinity-Bead Assisted Mass Spectrometry for Proteomics

Affinity-Bead Assisted Mass Spectrometry for Proteomics

Study: Blocking energy pathway helps reduce graft-versus-host disease

Study: Blocking energy pathway helps reduce graft-versus-host disease

Study shows COVID-19 vulnerability increases exponentially with age

Study shows COVID-19 vulnerability increases exponentially with age

Severe lymphatic disorder reversed through genetic sequencing and targeted treatment

Severe lymphatic disorder reversed through genetic sequencing and targeted treatment

Scientists discover small molecules that may reduce cellular stress

Scientists discover small molecules that may reduce cellular stress

Common diabetes drug controls aspects of inflammation in mice

Common diabetes drug controls aspects of inflammation in mice

Study provides new insights into the host cellular response to SARS-CoV-2 infection

Study provides new insights into the host cellular response to SARS-CoV-2 infection

People with accelerated biological age at increased risk of COVID-19 symptom severity and mortality

People with accelerated biological age at increased risk of COVID-19 symptom severity and mortality

Clemson researcher receives DOD grant to explore cellular underpinnings of developmental disorder

Clemson researcher receives DOD grant to explore cellular underpinnings of developmental disorder

Researchers discover key signaling pathway in the pathogenesis of Paget's disease

Researchers discover key signaling pathway in the pathogenesis of Paget's disease

Cell signaling pathway may offer new drugs for tuberous sclerosis complex

Cell signaling pathway may offer new drugs for tuberous sclerosis complex